ADAGIO THERAPEUTICS INC (ADGI) Forecast, Price Target & Analyst Ratings

NASDAQ:ADGI • US00534A1025

Current stock price

4.64 USD
+0.04 (+0.87%)
At close:
4.52 USD
-0.12 (-2.59%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADAGIO THERAPEUTICS INC (ADGI).

Forecast Snapshot

Consensus Price Target

Price Target
$3.91
-15.73% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2022
EPS Estimate
-$0.50
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
46.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.91
Upside
-15.73%
From current price of $4.64 to mean target of $3.91, Based on 9 analyst forecasts
Low
$3.03
Median
$3.57
High
$5.25

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ADGI. The average price target is 3.91 USD. This implies a price decrease of -15.73% is expected in the next year compared to the current price of 4.64.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ADGI Current Analyst RatingADGI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ADGI Historical Analyst RatingsADGI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
46.67%
ADGI was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about ADGI.
In the previous month the buy percentage consensus was at a similar level.
ADGI was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-05-17Morgan StanleyMaintains Underweight
2022-01-06Morgan StanleyDowngrade Equal-Weight -> Underweight
2021-12-22JefferiesDowngrade Buy -> Hold
2021-12-15GuggenheimDowngrade Buy -> Neutral
2021-12-15StifelDowngrade Buy -> Hold
2021-12-15Morgan StanleyDowngrade Overweight -> Equal-Weight
2021-11-29Morgan StanleyUpgrade Equal-Weight -> Overweight
2021-08-31GuggenheimInitiate Buy
2021-08-31StifelInitiate Buy
2021-08-31Morgan StanleyInitiate Equal-Weight
2021-08-31JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2022
EPS Estimate
-$0.50
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
48.65%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
ADGI revenue by date.ADGI revenue by date.
N/AN/AN/A
1,233.34%		N/A
145.10%		N/A
150.00%
EBITDA
YoY % growth
ADGI ebitda by date.ADGI ebitda by date.
N/A-226.907MN/A
3.35%		N/A
2.33%		N/A
56.26%		N/A
-26.76%		N/A
-29.29%
EBIT
YoY % growth
ADGI ebit by date.ADGI ebit by date.
-65.327M-226.908M
-247.34%		N/A
-12.80%		N/A
8.82%		N/A
36.34%		N/A
-20.18%		N/A
-22.58%
Operating Margin
ADGI operating margin by date.ADGI operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ADGI eps by date.ADGI eps by date.
N/AN/AN/A
-2.35%		N/A
17.36%		N/A
30.42%		N/A
-21.46%		N/A
-23.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-0.50
48.65%		-0.53
31.56%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-55.225M
8.60%		-57.568M
30.72%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ADGI Yearly Revenue VS EstimatesADGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 200M 400M 600M 800M
ADGI Yearly EPS VS EstimatesADGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.17%
EPS Next 5 Year
2.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ADAGIO THERAPEUTICS INC / ADGI Forecast FAQ

What do analysts expect the price target to be for ADAGIO THERAPEUTICS INC (ADGI)?

9 analysts have analysed ADGI and the average price target is 3.91 USD. This implies a price decrease of -15.73% is expected in the next year compared to the current price of 4.64.

What are the consensus estimates for ADGI stock next earnings?

The consensus EPS estimate for the next earnings of ADAGIO THERAPEUTICS INC (ADGI) is -0.5 USD and the consensus revenue estimate is 0 USD.